The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 26, 2025
Filed:
Jul. 11, 2019
Applicant:
The Brigham and Women's Hospital, Inc., Boston, MA (US);
Inventor:
Fengfeng Bei, Boston, MA (US);
Assignee:
The Brigham and Women's Hospital, Inc., Boston, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/005 (2006.01); A61K 31/522 (2006.01); A61K 35/761 (2015.01); A61K 38/45 (2006.01); A61K 48/00 (2006.01); A61K 49/00 (2006.01); A61P 35/00 (2006.01); C07K 14/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 31/522 (2013.01); A61K 35/761 (2013.01); A61K 38/45 (2013.01); A61K 48/0008 (2013.01); A61K 49/0045 (2013.01); A61K 49/0097 (2013.01); A61P 35/00 (2018.01); C07K 14/001 (2013.01); A61K 38/00 (2013.01); C07K 2319/00 (2013.01); C12N 2750/14122 (2013.01); C12N 2750/14143 (2013.01);
Abstract
The present invention is based on the development of artificial targeting sequences that enhance permeation of agents into cells and across the blood brain barrier, compositions comprising the sequences, and methods of use thereof. Provided herein is an AAV comprising a capsid protein comprising a targeting sequence and a transgene, preferably a therapeutic or diagnostic transgene. Further, provided herein are methods of delivering a transgene to a cell, the method comprising contacting the cell with an AAV or fusion protein described herein.